660ml revenue annually for their current product and looking to expand further into eruope.
so will approach 1billion revenue globally soon.
So whats the opportunity to lower their cost base on that revenue by 50%= substantial bottom line improvements.
Very compelling story unfolding here.
ive only got 60,000 shares but think this could be a very good investment in the next 12-18 months
- Forums
- ASX - By Stock
- EMD
- Ann: EMD-RX5 program advancing Phase 1 clinical trials underway
EMD
emyria limited
Add to My Watchlist
9.68%
!
3.4¢

Ann: EMD-RX5 program advancing Phase 1 clinical trials underway, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.4¢ |
Change
0.003(9.68%) |
Mkt cap ! $20.78M |
Open | High | Low | Value | Volume |
3.0¢ | 3.4¢ | 3.0¢ | $209.6K | 6.565M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 136872 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 546220 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.034 |
3 | 155625 | 0.032 |
2 | 382258 | 0.031 |
1 | 60000 | 0.030 |
3 | 260000 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 1165220 | 4 |
0.035 | 392200 | 3 |
0.036 | 189999 | 2 |
0.039 | 165533 | 4 |
0.040 | 428333 | 3 |
Last trade - 16.10pm 17/07/2025 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |